0001209191-17-052585.txt : 20170913 0001209191-17-052585.hdr.sgml : 20170913 20170913160906 ACCESSION NUMBER: 0001209191-17-052585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170911 FILED AS OF DATE: 20170913 DATE AS OF CHANGE: 20170913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FALVEY MICHAEL CENTRAL INDEX KEY: 0001286197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 171083275 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 85 WELLS AVENUE, 2ND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-11 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001286197 FALVEY MICHAEL C/O KARYOPHARM THERAPEUTICS INC. NEWTON MA 02459 0 1 0 0 EVP, CFO & Treasurer Nonstatutory Stock Option (right to buy) 10.60 2017-09-11 4 A 0 125000 0.00 A 2027-09-10 Common Stock 125000 125000 D This option was granted on September 11, 2017. The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ Christopher B. Primiano, Attorney-in-Fact for Michael Falvey 2017-09-13